Mesalamine Tablet, Delayed Release
Product Images NDC 0904-6832

2 FDA label images from Major Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mesalamine (NDC 0904-6832). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (A80b40d7 4498 4dfa B5ff B29ee69471a9 01)

Image (A80b40d7 4498 4dfa B5ff B29ee69471a9 01)
Chemical structure diagram of mesalamine showing a benzene ring with attached amino, hydroxyl, and carboxyl functional groups.*
FDA Label Image

1.2g Carton Label (D9ce9589 6aee 4dc3 A71b F1c32ab9f552 00)

1.2g Carton Label (D9ce9589 6aee 4dc3 A71b F1c32ab9f552 00)
Label for Major Pharmaceuticals Mesalamine Delayed-Release Tablets, USP, 1.2 g dosage strength. The label shows a unit dose package containing 30 tablets (3 x 10) with instructions to take once daily. It includes storage instructions, pharmacist dispensing guidelines, and manufacturer details indicating packaging and distribution by Major Pharmaceuticals in Indianapolis, IN. The package is labeled for institutional use only and includes an NDC 0904-6832-04 barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.